Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point
On Air
Feedback
Low Graphics
Help

Thursday, October 1, 1998 Published at 10:42 GMT 11:42 UK


Health

Breast cancer vaccine on trial

A simple injection could prolong life

The Imperial Cancer Research Fund has announced the start of a large scale trial of a vaccine to treat breast cancer.


The BBC's Pallab Ghosh: "Encouraging results"
The study will involve more than 900 women worldwide and aims to show if the disease can be controlled by a simple monthly injection.

It will initially involve women with the disease in its advanced stages.

Standard treatments

When a woman is diagnosed as having breast cancer, doctors will first surgically remove any lumps.

They must then destroy any remaining cells using chemotherapy, a powerful cocktail of anti-cancer drugs.

However, chemotherapy has unpleasant side-effects and can be ineffective.


Dr David Miles explains how the vaccine works
Dr David Miles, a consultant at Guy's and St Thomas's hospital, London, is co-ordinating the trial of the new vaccine.

He said: "Advanced breast cancer can be difficult to treat. The main aim is often to control the disease while allowing the patient to live as normal a life as possible.


[ image: Results so far have been promising]
Results so far have been promising
"This treatment appears to have few side-effects, can be easily applied once a month by injection, and allows patients to live their lives with what we hope will be minimal discomfort."

But Dr Miles said that even if the trial proves a success, the vaccine is unlikely to replace chemotherapy.

It would be used alongside the current treatments.

Immune response

The vaccine is thought to work by using the body's immune system.

Normally the immune system does not recognise cancerous cells as a threat, and so they are left to grow unhindered.

The vaccine is thought to work by "marking" cancers.

Normal cells have a protective coating of sugars around their core. In breast cancer cells, much of the coating is missing.

This means that sugars closer to the core are exposed.

Cancer cells destroyed

The vaccine targets one of these sugars, known as STn.

Antibodies in the immune system can then home in on the cancer cells and destroy them.

Early studies have shown promising results.

Dr Miles said: "Data from the studies suggest that the vaccine could help keep the disease at bay and prolong patients' lives.

"But the only way to be sure is by doing a much bigger study."

He said it would take four to five years before researchers knew the real value of the vaccine.



Advanced options | Search tips




Back to top | BBC News Home | BBC Homepage | ©


Health Contents

Background Briefings
Medical notes

Relevant Stories

28 Sep 98 | Health
Ginger Spice: 'I feared mastectomy'

23 Sep 98 | Medical notes
Breast cancer factfile

17 Sep 98 | Health
Chemotherapy that beats breast cancer

07 Aug 98 | Health
Tamoxifen could be first cancer prevention treatment





Internet Links


Imperial Cancer Research Fund

Breakthrough Breast Cancer

Guy's and St Thomas' Hospital Trust


The BBC is not responsible for the content of external internet sites.




In this section

Disability in depth

Spotlight: Bristol inquiry

Antibiotics: A fading wonder

Mental health: An overview

Alternative medicine: A growth industry

The meningitis files

Long-term care: A special report

Aids up close

From cradle to grave

NHS reforms: A guide

NHS Performance 1999

From Special Report
NHS in crisis: Special report

British Medical Association conference '99

Royal College of Nursing conference '99